Search research articles
Contact Us
Filters
Showing results (1-10 of 61) with videos related to
Page
of 7
Sort By:
Reproductive Biomedicine Online
|
July 20, 2004
Genetic contributions to glucose intolerance in polycystic ovary syndrome
David A Ehrmann
Current Diabetes Reports
|
March 20, 2003
Insulin resistance and polycystic ovary syndrome
David A Ehrmann
Steroids
|
December 20, 2011
Metabolic dysfunction in pcos: Relationship to obstructive sleep apnea
David A Ehrmann
Clinical Medicine Insights. Reproductive Health
|
September 14, 2019
Pathogenesis and Consequences of Disordered Sleep in PCOS
Susan Sam, David A Ehrmann
Seminars in Reproductive Medicine
|
November 1, 2003
Pharmacologic treatment of polycystic ovary syndrome
David A Ehrmann, Daniel Rychlik
Clinical Obstetrics and Gynecology
|
February 17, 2007
Pharmacologic therapy of polycystic ovary syndrome
Suma Dronavalli, David A Ehrmann
Fertility and Sterility
|
May 5, 2022
Nonalcoholic fatty liver disease and obstructive sleep apnea in women with polycystic ovary syndrome
Iliana Doycheva, David A Ehrmann
Best Practice & Research. Clinical Endocrinology & Metabolism
|
November 30, 2010
Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome
Katie Nitsche, David A Ehrmann
Diabetologia
|
August 4, 2017
Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome
Susan Sam, David A Ehrmann
Endocrine Reviews
|
July 27, 2016
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited
Robert L Rosenfield, David A Ehrmann
Page
of 7
Search research articles
Search
Showing results (1-10 of 61) with videos related to
Sort By:
Page
of 7
Reproductive Biomedicine Online
|
July 20, 2004
Genetic contributions to glucose intolerance in polycystic ovary syndrome
David A Ehrmann
Current Diabetes Reports
|
March 20, 2003
Insulin resistance and polycystic ovary syndrome
David A Ehrmann
Steroids
|
December 20, 2011
Metabolic dysfunction in pcos: Relationship to obstructive sleep apnea
David A Ehrmann
Clinical Medicine Insights. Reproductive Health
|
September 14, 2019
Pathogenesis and Consequences of Disordered Sleep in PCOS
Susan Sam, David A Ehrmann
Seminars in Reproductive Medicine
|
November 1, 2003
Pharmacologic treatment of polycystic ovary syndrome
David A Ehrmann, Daniel Rychlik
Clinical Obstetrics and Gynecology
|
February 17, 2007
Pharmacologic therapy of polycystic ovary syndrome
Suma Dronavalli, David A Ehrmann
Fertility and Sterility
|
May 5, 2022
Nonalcoholic fatty liver disease and obstructive sleep apnea in women with polycystic ovary syndrome
Iliana Doycheva, David A Ehrmann
Best Practice & Research. Clinical Endocrinology & Metabolism
|
November 30, 2010
Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome
Katie Nitsche, David A Ehrmann
Diabetologia
|
August 4, 2017
Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome
Susan Sam, David A Ehrmann
Endocrine Reviews
|
July 27, 2016
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited
Robert L Rosenfield, David A Ehrmann
Page
of 7